Gene-Disorder Association · Article
Gene
ATM ATM Serine/Threonine Kinase
×
First reported
1997
Supporting publications
271
Manually curated Approved treatment annotated
Association Review
In brief The association between ATM (ATM Serine/Threonine Kinase) and Breast Cancer is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording a known molecular basis, likely-pathogenic variants, and a susceptibility locus.
Sources
3
Clinical variants
5,917
Symptoms
4
Compounds
8
Trials
1,523 of 10,652 via ATM compounds
Publications
271
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access 02
Provenance
Evidence and sources 3 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access 3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access 04
Breast Cancer
The disorder 23 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access 05
Phenotype
Clinical features 1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access 06
ClinVar and variant evidence
Genetic basis 5,917 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access 07
Genomic context
Regulatory context 2 regulatory elements
GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.
Request access 08
Mechanism overlap
Shared mechanisms 1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access 09
Interventions
Therapeutics 8 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access 10
Human studies
Clinical trials 10,652 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access 271 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access 12
Provenance
References & sources 23 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access 
